Table 3.
Results for 163 patients with cutaneous leishmaniasis (Leishmania major infection) acquired in northern Afghanistan treated with intralesional pentavalent antimony with or without cryotherapy in Mazar-e-Sharif, Afghanistan, the Academic Medical Center, Amsterdam, The Netherlands, or in both locations*
| Result | M-e-S,† ilSbv, no. (%) (n = 118) | AMC, ilSbv plus cryotherapy, no. (%) (n = 45) |
|---|---|---|
| Secondary miltefosine | 24 (20.3) | 6 (13.3) |
| Definite cure | 65 (55.1) | 30 (66.7) |
| Probable cure | 16 (13.6) | 6 (13.3) |
| Unknown | 13 (11.0) | 3 (6.7) |
*
Three of 172 patients were treated elsewhere, 4 received other treatment, 1 refused treatment, and 1 experienced spontaneous cure. MeS = Mazar-e-Sharif, Afghanistan; ilSBv = with intralesional pentavalent antimony; AMC = Academic Medical Center, Amsterdam, The Netherlands
†
Twenty-one persons who started treatment at M-e-S continued treatment in AMC after redeployment; 17 with the addition of cryotherapy and 9 because of recurrence.